EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Secondary Sites of the C‐type Lectin‐Like Fold

Jonathan Lefèbre iD, Torben Falk iD, Yunzhan Ning iD, Christoph Rademacher iD

Chemistry – A European Journal · 2024

DOI: 10.1002/chem.202400660 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Jonathan Lefèbre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Lectins, C-Type. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vienna Science and Technology Fund, H2020 European Research Council, Österreichische Forschungsförderungsgesellschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C‐type lectins are a large superfamily of proteins involved in a multitude of biological processes. In particular, their involvement in immunity and homeostasis has rendered them attractive targets for diverse therapeutic interventions. They share a characteristic C‐type lectin‐like domain whose adaptability enables them to bind a broad spectrum of ligands beyond the originally defined canonical Ca 2+ ‐dependent carbohydrate binding. Together with variable domain architecture and high‐level conformational plasticity, this enables C‐type lectins to meet diverse functional demands. Secondary sites provide another layer of regulation and are often intricately linked to functional diversity. Located remote from the canonical primary binding site, secondary sites can accommodate ligands with other physicochemical properties and alter protein dynamics, thus enhancing selectivity and enabling fine‐tuning of the biological response. In this review, we outline the structural determinants allowing C‐type lectins to perform a large variety of tasks and to accommodate the ligands associated with it. Using the six well‐characterized Ca 2+ ‐dependent and Ca 2+ ‐independent C‐type lectin receptors DC‐SIGN, langerin, MGL, dectin‐1, CLEC‐2 and NKG2D as examples, we focus on the characteristics of non‐canonical interactions and secondary sites and their potential use in drug discovery endeavors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lectins, C-TypeHumansLigandsBinding SitesCalciumReceptors, Cell SurfaceCell Adhesion MoleculesProtein BindingMannose-Binding LectinsMannose-Binding LectinNK Cell Lectin-Like Receptor Subfamily KAntigens, CDDC-Specific ICAM-3 Grabbing NonintegrinDectin-1

Substanzen

Lectins, C-TypeLigandsCalciumReceptors, Cell SurfaceCell Adhesion MoleculesMannose-Binding LectinsMannose-Binding LectinNK Cell Lectin-Like Receptor Subfamily KAntigens, CDDC-Specific ICAM-3 Grabbing Nonintegrin

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
  • Vienna Doctoral School of Pharmaceutical, Nutritional and Sport, Sciences, University of Vienna, Vienna, Austria.
  • Department of Microbiology, Immunology and Genetics, University of Vienna, Max F. Perutz Labs, Vienna, Austria.

ORCID-Profile: Jonathan Lefèbre, Torben Falk, Yunzhan Ning, Christoph Rademacher

Förderung

  • Vienna Science and Technology Fund
  • H2020 European Research Council
  • Österreichische Forschungsförderungsgesellschaft
  • European Research Council
  • Austrian Science Fund FWF

Zitieren

APA

Lefèbre, J., Falk, T., Ning, Y., & Rademacher, C. (2024). Secondary Sites of the C‐type Lectin‐Like Fold. Chemistry – A European Journal. https://doi.org/10.1002/chem.202400660

Vancouver

Lefèbre J, Falk T, Ning Y, Rademacher C. Secondary Sites of the C‐type Lectin‐Like Fold. Chemistry – A European Journal. 2024. doi:10.1002/chem.202400660

BibTeX
@article{Lefbre2024,
  author = {Lefèbre, Jonathan and Falk, Torben and Ning, Yunzhan and Rademacher, Christoph},
  title = {Secondary Sites of the C‐type Lectin‐Like Fold},
  journal = {Chemistry – A European Journal},
  year = {2024},
  doi = {10.1002/chem.202400660}
}
Kostenlos starten →